| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/23/2013 | US20130129744 Plasminogen-activating antibody, use and producing method thereof and agent including the same |
| 05/23/2013 | US20130129743 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE |
| 05/23/2013 | US20130129742 Human leukolectins and uses thereof |
| 05/23/2013 | US20130129741 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 05/23/2013 | US20130129739 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 05/23/2013 | US20130129738 Pharmaceutical composition |
| 05/23/2013 | US20130129737 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof |
| 05/23/2013 | US20130129735 Antibodies to egfl7 and methods for their use |
| 05/23/2013 | US20130129733 Humanized anti-egfl7 antibodies and methods using same |
| 05/23/2013 | US20130129732 Method for preserving food |
| 05/23/2013 | US20130129731 Anti c-met antibody and uses thereof |
| 05/23/2013 | US20130129730 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| 05/23/2013 | US20130129729 Compositions comprising cross-species-specific antibodies and uses thereof |
| 05/23/2013 | US20130129728 Antibodies to the c3d fragment of complement component 3 |
| 05/23/2013 | US20130129726 Peptide having cell membrane penetrating activity |
| 05/23/2013 | US20130129725 Human fgf receptor and beta-klotho binding proteins |
| 05/23/2013 | US20130129723 Heterodimer Binding Proteins and Uses Thereof |
| 05/23/2013 | US20130129722 Methods for Treating Cancer by Administering an Anti-Ang-2 Antibody |
| 05/23/2013 | US20130129721 Humanized Anti-C5aR Antibodies |
| 05/23/2013 | US20130129718 Purification of anti-c-met antibodies |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129714 Prevention and treatment of cast nephropathy |
| 05/23/2013 | US20130129617 Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody |
| 05/23/2013 | CA2856154A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute_condition |
| 05/23/2013 | CA2856150A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | CA2856142A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizingthe circulation |
| 05/23/2013 | CA2856141A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | CA2856136A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | CA2855864A1 Bi-specific antibodies for medical use |
| 05/23/2013 | CA2855822A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a |
| 05/23/2013 | CA2855746A1 Methods of treating epidermal growth factor deletion mutant viii related disorders |
| 05/23/2013 | CA2853883A1 Antibodies for molecular imaging of vulnerable plaques in atherosclerosis |
| 05/23/2013 | CA2852994A1 Anti il-36r antibodies |
| 05/23/2013 | CA2850591A1 Binding molecules for bcma and cd3 |
| 05/23/2013 | CA2849196A1 Binding molecules for bcma and cd3 |
| 05/22/2013 | EP2594943A1 Method for detecting malignant tumor cells |
| 05/22/2013 | EP2594591A2 TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease |
| 05/22/2013 | EP2594590A1 Binding molecules to the human OX40 receptor |
| 05/22/2013 | EP2594589A1 ANTI-Trop-2 ANTIBODY |
| 05/22/2013 | EP2594588A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or an anti-ADM non-Ig scaffold for use in therapy |
| 05/22/2013 | EP2594587A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/22/2013 | EP2594586A1 IL-31 monoclonal antibodies and methods of use |
| 05/22/2013 | EP2594585A1 Methods of treating pain and inflammation in neuronal tissue using IL-31 antagonists |
| 05/22/2013 | EP2594584A1 Engineered constant domain molecule of an antibody |
| 05/22/2013 | EP2593595A2 Novel peptides and uses thereof |
| 05/22/2013 | EP2593551A1 Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides |
| 05/22/2013 | EP2593550A1 Diagnostic method for colitis |
| 05/22/2013 | EP2593483A2 Combination pharmaceutical composition and methods of treating genitourinary system disorders |
| 05/22/2013 | EP2593482A2 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 05/22/2013 | EP2593481A1 Use of antibodies against icam-1 in the treatment of patients with relapsed cancer |
| 05/22/2013 | EP2593480A2 Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides |
| 05/22/2013 | EP2593479A1 Superior efficacy of cd37 antibodies in cll blood samples |
| 05/22/2013 | EP2593478A1 Rnf8-fha domain-modified protein and method of producing the same |
| 05/22/2013 | EP2593477A2 Pharmaceutical compositions and methods of treatment |
| 05/22/2013 | EP2593476A2 Modified single domain antigen binding molecules and uses thereof |
| 05/22/2013 | EP2593475A2 Anti-addl monoclonal antibody and uses thereof |
| 05/22/2013 | EP2593474A2 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| 05/22/2013 | EP2593467A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 05/22/2013 | EP2593142A1 Multifunctional antibody conjugates |
| 05/22/2013 | EP2593140A2 A method of increasing the effect of an activated-potentiated form of an antibody |
| 05/22/2013 | EP2593138A2 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 05/22/2013 | EP2593137A1 Stabilized formulations containing anti-ngf antibodies |
| 05/22/2013 | EP2593128A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 05/22/2013 | CN103119066A Compound having activity for inhibiting tgf- belta receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases |
| 05/22/2013 | CN103119065A Human antibody drug conjugates against tissue factor |
| 05/22/2013 | CN103119064A Fab-glycosylated antibodies |
| 05/22/2013 | CN103119063A Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (VEGFR- 2 /KDR) |
| 05/22/2013 | CN103119062A Modified single domain antigen binding molecules and uses thereof |
| 05/22/2013 | CN103119061A A method of treating attention deficit hyperactivity disorder |
| 05/22/2013 | CN103119060A A method of treating alzheimer's disease |
| 05/22/2013 | CN103119059A Novel mutated humanized 12G4 antibodies and the fragments thereof against the human anti-mullerian hormone receptor type II |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103118707A A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
| 05/22/2013 | CN103118706A Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and NHL |
| 05/22/2013 | CN103118705A Concentrated human immunoglobulin composition |
| 05/22/2013 | CN103114096A Variable regions of heavy chain and light chain of antibody and antibody for assisting PBC (Primary Biliary Cirrhosis) diagnosis |
| 05/22/2013 | CN103114079A Preparation of serologic H-Y antigen gene DBY antibody and XY sperm immune sorting method thereof |
| 05/22/2013 | CN103113471A Bispecific monoclonal antibody resisting clenbuterol hydrochloride and olaquindox and preparation method of bispecific monoclonal antibody |
| 05/22/2013 | CN103113470A Genetically engineered lymphocyte targeting Human EGFR (Epidermal Growth Factor Receptor), preparation method and application of genetically engineered lymphocyte |
| 05/22/2013 | CN103113469A Single-chain antibody for resisting vascular endothelial growth factor receptor 2 |
| 05/22/2013 | CN103113458A Hepatitis c virus B-cell epitope peptide PUHI34 and application thereof |
| 05/22/2013 | CN103113258A Sudan I derivatives as well as preparation method and application thereof |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101469019B Cellular membrane protein DERLIN-1, preparation and use thereof |
| 05/22/2013 | CN101456912B Anti P selectin single-chain antibody and use thereof |
| 05/22/2013 | CN101389655B Novel collection of HCDR3 regions and uses therefor |
| 05/22/2013 | CN101300273B TRAIL recipient 2 Polypeptides and antibodies |
| 05/21/2013 | US8445649 Antibody and use thereof |
| 05/21/2013 | US8445648 Methods and products relating to GSK3β regulation |
| 05/21/2013 | US8445646 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8445645 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445643 Anti-IRC85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof |
| 05/21/2013 | US8445642 Methods to differentiate protein conformers |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445410 Ligand screening and discovery |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |